文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全国肌萎缩侧索硬化症登记处:构建运动神经元疾病人群登记处的系统评价。

National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases.

机构信息

Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.

Department of Integrated Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.

出版信息

BMC Neurol. 2021 Jul 6;21(1):269. doi: 10.1186/s12883-021-02298-2.


DOI:10.1186/s12883-021-02298-2
PMID:34229610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8259351/
Abstract

BACKGROUND: This article comprises a systematic review of the literature that aims at researching and analyzing the frequently applied guidelines for structuring national databases of epidemiological surveillance for motor neuron diseases, especially Amyotrophic Lateral Sclerosis (ALS). METHODS: We searched for articles published from January 2015 to September 2019 on online databases as PubMed - U.S. National Institutes of Health's National Library of Medicine, Scopus, Science Direct, and Springer. Subsequently, we analyzed studies that considered risk factors, demographic data, and other strategic data for directing techno-scientific research, calibrating public health policies, and supporting decision-making by managers through a systemic panorama of ALS. RESULTS: 2850 studies were identified. 2400 were discarded for not satisfying the inclusion criteria, and 435 being duplicated or published in books or conferences. Hence, 15 articles were elected. By applying quality criteria, we then selected six studies to compose this review. Such researches featured registries from the American (3), European (2), and Oceania (1) continent. All the studies specified the methods for data capture and the patients' recruitment process for the registers. DISCUSSIONS: From the analysis of the selected papers and reported models, it is noticeable that most studies focused on the prospect of obtaining data to characterize research on epidemiological studies. Demographic data (ID01) are present in all the registries, representing the main collected data category. Furthermore, the general health history (ID02) is present in 50% of the registries analyzed. Characteristics such as access control, confidentiality and data curation. We observed that 50% of the registries comprise a patient-focused web-based self-report system. CONCLUSION: The development of robust, interoperable, and secure electronic registries that generate value for research and patients presents itself as a solution and a challenge. This systematic review demonstrated the success of a population register requires actions with well-defined development methods, as well as the involvement of various actors of civil society.

摘要

背景:本文是对文献的系统综述,旨在研究和分析常用于构建运动神经元疾病(尤其是肌萎缩侧索硬化症)国家流行病学监测数据库的指南。

方法:我们在 2015 年 1 月至 2019 年 9 月期间在在线数据库 PubMed(美国国立卫生研究院国家医学图书馆)、Scopus、Science Direct 和 Springer 上搜索了已发表的文章。随后,我们分析了考虑危险因素、人口统计学数据和其他用于指导技术科学研究、调整公共卫生政策和通过肌萎缩侧索硬化症的系统全景为管理者提供决策支持的战略数据的研究。

结果:共确定了 2850 项研究。2400 项因不符合纳入标准而被排除,435 项因重复或发表在书籍或会议上而被排除。因此,有 15 篇文章入选。通过应用质量标准,我们随后选择了 6 项研究来组成这篇综述。这些研究来自美洲(3 项)、欧洲(2 项)和大洋洲(1 项)的登记处。所有研究都指定了数据采集和患者招募过程的方法。

讨论:从所选论文和报告模型的分析中可以看出,大多数研究都侧重于获取数据以描述流行病学研究的前景。人口统计学数据(ID01)存在于所有登记处,是主要收集的数据类别。此外,分析的 50%的登记处存在一般健康史(ID02)。访问控制、保密性和数据管理等特征。我们观察到,50%的登记处包含一个以患者为中心的基于网络的自我报告系统。

结论:开发强大、互操作和安全的电子登记处,为研究和患者创造价值,这既是一种解决方案,也是一种挑战。本系统综述表明,人口登记处的发展需要采取具有明确定义的开发方法的行动,以及民间社会各方面的参与。

相似文献

[1]
National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases.

BMC Neurol. 2021-7-6

[2]
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.

MMWR Surveill Summ. 2016-8-5

[3]
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.

MMWR Suppl. 2014-7-25

[4]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[5]
Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.

Neuroepidemiology. 2019-5-22

[6]
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.

Cochrane Database Syst Rev. 2017-10-6

[7]
Coping in people with amyotrophic lateral sclerosis and motor neuron disease: Systematic review.

J Clin Nurs. 2021-7

[8]
Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism.

J Med Internet Res. 2021-12-7

[9]
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.

Cochrane Database Syst Rev. 2008-4-16

[10]
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.

Med J Aust. 2020-12

引用本文的文献

[1]
Data Report: Educational pathway addressing food and nutrition in amyotrophic lateral sclerosis on the AVASUS platform.

Front Digit Health. 2025-1-6

[2]
Blockchain in Health Information Systems: A Systematic Review.

Int J Environ Res Public Health. 2024-11-14

[3]
Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States.

Mayo Clin Proc Innov Qual Outcomes. 2024-9-17

[4]
Educommunication in Nutrition and Neurodegenerative Diseases: A Scoping Review.

Int J Environ Res Public Health. 2024-8-22

[5]
Evaluation of the therapeutic effects of rehabilitation therapy on patients with amyotrophic lateral sclerosis-a meta-analysis.

Front Neurol. 2024-5-3

[6]
Digital health solution for monitoring and surveillance of Amyotrophic Lateral Sclerosis in Brazil.

Front Public Health. 2023

[7]
Digital Alternative Communication for Individuals with Amyotrophic Lateral Sclerosis: What We Have.

J Clin Med. 2023-8-11

[8]
Electronic health records in Brazil: Prospects and technological challenges.

Front Public Health. 2022

[9]
Translational research in health technologies: A scoping review.

Front Digit Health. 2022-8-3

本文引用的文献

[1]
Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review.

Biomed Eng Online. 2021-6-15

[2]
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

BMJ. 2021-3-29

[3]
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature.

Curr Opin Neurol. 2019-10

[4]
Establishment and 12-month progress of the New Zealand Motor Neurone Disease Registry.

J Clin Neurosci. 2019-2

[5]
The Swedish motor neuron disease quality registry.

Amyotroph Lateral Scler Frontotemporal Degener. 2018-11

[6]
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.

Orphanet J Rare Dis. 2018-10-4

[7]
MOVR-NeuroMuscular ObserVational Research, a unified data hub for neuromuscular diseases.

Genet Med. 2019-3

[8]
The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities.

Paediatr Child Health. 2018-2

[9]
An overview of the impact of rare disease characteristics on research methodology.

Orphanet J Rare Dis. 2018-1-19

[10]
CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.

MMWR Morb Mortal Wkly Rep. 2017-12-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索